Anúncio
Anúncio
ANAB
AnaptysBio, Inc. Common Stock
44.61
USDPatrocinado
+0.81
+1.86%
09 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
44.63
+0.01
+0.03%
Relatórios de Lucros ANAB
Rácio de surpresa positiva
ANAB separação 22 de 36 últimas estimativas.
61%
Próximo Relatório
Data do Próximo Relatório
25 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$94.66M
/$0.96
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+24.03%
/+84.62%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+119.57%
/-233.33%
AnaptysBio, Inc. Common Stock earnings per share and revenue
On 04 de nov. de 2025, ANAB reported earnings of 0.52 USD per share (EPS) for Q3 25, beating the estimate of -1.48 USD, resulting in a 134.93% surprise. Revenue reached 76.32 milhão, compared to an expected 16.13 milhão, with a 373.23% difference. The market reacted with a +3.63% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 13 analistas forecast an EPS of 0.96 USD, with revenue projected to reach 94.66 milhão USD, implying an aumentar of 84.62% EPS, and aumentar of 24.03% in Revenue from the last quarter.
FAQ
What were AnaptysBio, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, AnaptysBio, Inc. Common Stock reported EPS of $0.52, beating estimates by 134.93%, and revenue of $76.32M, 373.23% above expectations.
How did the market react to AnaptysBio, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 3.63%, changed from $34.74 before the earnings release to $36.00 the day after.
When is AnaptysBio, Inc. Common Stock expected to report next?
The next earning report is scheduled for 25 de fev. de 2026.
What are the forecasts for AnaptysBio, Inc. Common Stock's next earnings report?
Based on 13
analistas, AnaptysBio, Inc. Common Stock is expected to report EPS of $0.96 and revenue of $94.66M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio